Allan Pamba was appointed Director Public Engagement & Access Initiatives at GlaxoSmithKline in January 2011. His role focuses on the sustainable delivery of GSK medicines and vaccines to developing countries via innovative business models.
He is also responsible for directing GSK’s external engagement activities and setting up innovative initiatives to enhance access to medicines and vaccines across 50 countries, including the UN 48 Least Developed Countries.
Allan trained as a physician in Kenya and worked in clinical care in the country for government services, mission hospitals and research hospitals. He conducted clinical trials on the management of severe malaria in children at the WellcomeTrust Research Unit in Kilifi, Kenya and established one of the country’s first HIV Comprehensive Care Clinics.
He joined GSK in 2005 and was initially involved in strategic and tactical leadership of R&D programmes in Diseases of the Developing World, in particular HIV and malaria. He led medical governance for over 30 large HIV collaborative trials in Africa and Asia and led a phase III clinical development programme with two large trials in Africa developing a new anti-malarial medication.
He has an MSc in Public Health in Developing Countries from the London School of Hygiene & Tropical Medicine.
By the way, let us also appreciate that many microfinance institutions are charging reasonable...
NextBillion.net | NexThought Monday - Why Did Vittana Close Down? · 6 hours ago
Hi Paul, I love your model! I'd love to connect. Our company follows a similar philosophy and I'd...
NextBillion.net | Training Africa’s “Micropreneurs” · 7 hours ago
Two points, James, in response to your perspective. One, being a not-for-profit and not...
NextBillion.net | NexThought Monday - Why Did Vittana Close Down? · 20 hours ago
Kate -- Thank you. I look forward to reading it.
NextBillion.net | NexThought Monday - Why Did Vittana Close Down? · 1 day ago
John, I don't think your analogy holds up in this case. If a non-profit organization tries to...